ePS1.06 Evolution of psychological distress during progression of the COVID-19 pandemic in adults with cystic fibrosis

por Cresta, F., Ciprandi, R., Castellani, C., Pescini, R., Casciaro, R., Schiavetti, I.
Publicado 2022

ePS1.04 Sleep disturbances in children with cystic fibrosis at the beginning and in the first year of the COVID-19 pandemic

por Eyuboglu, T. Sismanlar, Aslan, A.T., Gursoy, T. Ramasli, Asfuroglu, P., Soysal, A.S., Yapar, D., Ilhan, M.N.
Publicado 2022

WS21.01 AQP5 and CFTR, two genes associated with pseudo-aquagenic palmoplantar keratoderma?

por Girodon, E., Lopez, M., Sperelakis-Beedham, B., Bourrat, E., Gaitch, N., Houriez, F., Martinez, B., Fajac, I., Burgel, P.-R., Hickman, G., Audrézet, M.-P., Guerrot, A.-M., Cabet, F., Gerfaud-Valentin, M., Nove-Josserand, R., Raynal, C., Pagin, A., Reboul, M.-P., De Becdelièvre, A., Callebaut, I., Bienvenu, T.
Publicado 2022

P073 Observed impact on admissions during the COVID-19 pandemic of paediatric cystic fibrosis patients in a tertiary hospital setting

por Warraich, S., Lock, K., Hamilton, C., Selby, L.
Publicado 2022

ePS4.04 Evaluation of burden of the COVID-19 pandemic among the cystic fibrosis community in Brno, Czech Republic

por Mala, M., Homola, L., Pokojova, E., Stastna, N., Holcikova, A., Gracova, Z.
Publicado 2022

P077 Vaccination of patients with cystic fibrosis during the COVID-19 pandemic in Croatia

por Markelić, I., Palković, T. Odobašić, Bambir, I., Milinković, T., Tješić-Drinković, D., Dugac, A. Vukić
Publicado 2022

254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health

por Sakon, C., Vogt, H., Brown, C., Tillman, E.
Publicado 2022

433 Differential small ribonucleic acid expression analysis reveals transforming growth factor beta role in SARS-CoV-2 infection of the cystic fibrosis airway

por Hejenkowska, E., Mitash, N., Donovan, J., Mu, F., Beer Stolz, D., Bertrand, C., Swiatecka-Urban, A.
Publicado 2022

48 Longitudinal outcomes of adults and children with cystic fibrosis during the COVID-19 pandemic

por Doumit, M., Chuang, S., Middleton, P., Selvadurai, H., Sivam, S., Ruseckaite, R., Ahern, S., Mallitt, K., Pacey, V., Gray, K., Jaffe, A.
Publicado 2022

510 Prevalence and clinical impact of respiratory viral infections in the Standardized Treatment of Pulmonary Exacerbations 2 Study

por Thornton, C., Kalikin, L., Sanders, D., McClellan, S., LeBar, W., VanDevanter, D., Heltshe, S., Caverly, L., LiPuma, J.
Publicado 2022

385 Mechanisms by which cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection

por Tedbury, P., Manfredi, C., Conway, J., Horwath, M., McCracken, C., Sorscher, A., Moreau, S., Wright, C., Edwards, C., Brewer, J., Guarner, J., De Wit, E., Williamson, B., Ong, Y., Roback, J., Alter, D., Degenhardt, F., Karlsen, T., Franke, A., Sarafianos, S., Sorscher, E., Hong, J., Ehrhardt, A.
Publicado 2022

634 Generation of a cystic fibrosis transmembrane conductance regulator R1162X “TAG” model and comparison of readthrough to the naturally occurring R1162X “TGA”

por Bukis, K., Cheng, Y., Armstrong, M., Conte, J., Coote, K., Allaire, N., Sivachenko, A., Mense, M., Cotton, C., Valley, H.
Publicado 2022

486 Genomic barcoding of Pseudomonas aeruginosa is a high-throughput technique for studying evolutionary dynamics with single-cell resolution

por Clay, M., Cooper, V.
Publicado 2022

67 Implementation of a health screening process for cystic fibrosis care during the COVID-19 pandemic

por Evangelista, B., Murray, R., List, R., Albon, D., Bruschwein, H., Compton, M., Jennings, D., Turner, R., Somerville, L.
Publicado 2022

250 Dosing and therapeutic drug monitoring of intravenous vancomycin in cystic fibrosis: A practice survey

por Dagenais, R., Su, V., Cen, R.
Publicado 2022

37 Trends in Canadian cystic fibrosis health care use amidst the COVID-19 pandemic

por Le, T., Cheng, S., Wallenburg, J., Stephenson, A.
Publicado 2022

445 Inflammation in normal COVID-19 airway due to inhibition of cystic fibrosis transmembrane conductance regulator signaling by the SARSCoV-2 Spike protein

por Caohuy, H., Eidelman, O., Chen, T., Yang, Q., Walton, N., Pollard, H.
Publicado 2022

439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells

por Sorio, C., Lotti, V., Merigo, F., Lagni, A., Di Clemente, A., Ligozzi, M., Bernardi, P., Rossini, G., Concia, E., Plebani, R., Romano, M., Sbarbati, A., Gibellini, D.
Publicado 2022

440 Novel mechanism of transforming growth factor beta-1 signaling in human bronchial epithelia

por Donovan, J., Cruz, D., Hejenkowska, E., Mu, F., Farinha, C., Swiatecka-Urban, A.
Publicado 2022

31 Sleep disturbance and school engagement in children with cystic fibrosis during the COVID-19 pandemic

por Wisniewski, B., Swegheimer, K., Boat, T., Hjelm, M.
Publicado 2022